Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies

ClinicalTrials.gov ID: NCT02097745

Public ClinicalTrials.gov record NCT02097745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 4:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Study of the Efficacy and Safety of Re-treatments With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNFa Therapies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the long-term safety and efficacy of repeating treatment with MabThera, in combination with methotrexate and steroids, in patients who were previously randomized into MabThera study WA17042. The anticipated time on study treatment is until Mabthera is available on the local market and the target sample size is 100-500 individuals.

Study identification

NCT ID
NCT02097745
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
341 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
May 31, 2013
Completion
May 31, 2013
Last update posted
Nov 2, 2016

2004 – 2013

United States locations

U.S. sites
59
U.S. states
24
U.S. cities
50
Facility City State ZIP Site status
Not listed Mesa Arizona 85208
Not listed Paradise Valley Arizona 85253
Not listed Tucson Arizona 85724
Not listed Little Rock Arkansas 72205
Not listed Fullerton California 92835
Not listed Los Angeles California 90045
Not listed Los Angeles California 90048
Not listed Pasadena California 91105
Not listed Rancho Mirage California 92270
Not listed Santa Maria California 93454
Not listed Danbury Connecticut 06810
Not listed Boca Raton Florida 33486
Not listed Delray Beach Florida 33484
Not listed Fort Lauderdale Florida 33334
Not listed Jupiter Florida 33458
Not listed Orlando Florida 32806
Not listed Boise Idaho 83702
Not listed Coeur d'Alene Idaho 83814
Not listed Meridian Idaho 83642
Not listed Chicago Illinois 60612
Not listed Chicago Illinois 60637
Not listed Indianapolis Indiana 46202-5149
Not listed Indianapolis Indiana 46260
Not listed Shreverport Louisiana 71103
Not listed Baltimore Maryland 21224
Not listed Boston Massachusetts 02215
Not listed Kalamazoo Michigan 49048
Not listed Lansing Michigan 48910
Not listed Rochester Minnesota 55905
Not listed St Louis Missouri 63110
Not listed St Louis Missouri 63141
Not listed Albany New York 12206
Not listed Manhasset New York 11030
Not listed New York New York 10003
Not listed Rochester New York 14618
Not listed Smithtown New York 11787
Not listed Chapel Hill North Carolina 27599-7600
Not listed Greenville North Carolina 27834
Not listed Cincinnati Ohio 45267-0563
Not listed Dayton Ohio 45402
Not listed Mayfield Ohio 44143
Not listed Oklahoma City Oklahoma 73103
Not listed Oklahoma City Oklahoma 73109
Not listed Tulsa Oklahoma 74135
Not listed Duncansville Pennsylvania 16635
Not listed Philadelphia Pennsylvania 19140
Not listed Philadelphia Pennsylvania 19141
Not listed Philadelphia Pennsylvania 19152
Not listed Amarillo Texas 79124
Not listed Dallas Texas 75231
Not listed Dallas Texas 75246
Not listed Houston Texas 77074
Not listed Waco Texas 76710
Not listed Salt Lake City Utah 84132
Not listed Burlington Vermont 05401
Not listed Seattle Washington 98101
Not listed Seattle Washington 98104
Not listed Spokane Washington 99204
Not listed Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02097745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02097745 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →